0000874015-16-000135.txt : 20160906 0000874015-16-000135.hdr.sgml : 20160906 20160906185218 ACCESSION NUMBER: 0000874015-16-000135 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160901 FILED AS OF DATE: 20160906 DATE AS OF CHANGE: 20160906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARSHALL B LYNNE CENTRAL INDEX KEY: 0001073385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 161871831 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-09-01 0000874015 IONIS PHARMACEUTICALS INC IONS 0001073385 PARSHALL B LYNNE C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 1 0 0 COO Common Stock 2016-09-01 2016-09-01 4 M 0 8865 7.25 A 25558 D Common Stock 2016-09-01 2016-09-01 4 S 0 8865 29.8154 D 16693 D Common Stock 2016-09-01 2016-09-01 4 M 0 3635 14.69 A 20328 D Common Stock 2016-09-01 2016-09-01 4 S 0 3635 30.05 D 16693 D Employee Stock Options (right to buy) 7.25 2016-09-01 2016-09-01 4 M 0 8865 0 D 2016-01-03 2019-01-02 Common Stock 8865 0 D Employee Stock Option (right to buy) 14.69 2016-09-01 2016-09-01 4 M 0 3635 0 D 2014-01-02 2020-01-29 Common Stock 3635 24910 D Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 7/13/2016. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.80 to $30.05, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4. Grant of 1/30/2013 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/2/2014. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 15,570 shares per year. Following this transaction, the option was exercisable as to 18,422 on 9/1/2016. /s/B. Lynne Parshall 2016-09-06